Skin and diabetes.
Skin manifestations associated with diabetes mellitus are common and, with close scrutiny, can occur in most, if not all, patients. Little information is available on what common pathophysiologic thread is responsible for the skin manifestation and diabetes. Although controlled studies are lacking, a recognition of the skin manifestations, treatment, and prognosis will help patients and their caregivers to understand treatment alternatives more clearly.
Sibbald
R G
RG
Department of Medicine, University of Toronto, Ontario, Canada.
Landolt
S J
SJ
Toth
D
D
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000175:diagnosis / Q000209:etiology; D001768:Blister / Q000209:etiology / Q000503:physiopathology; D002177:Candidiasis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology; D005260:Female; D016460:Granuloma Annulare / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000009:adverse effects; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D009335:Necrobiosis Lipoidica / Q000209:etiology / Q000473:pathology / Q000628:therapy; D012592:Scleredema Adultorum / Q000209:etiology; D012867:Skin / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D012871:Skin Diseases / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D013453:Sulfonylurea Compounds / Q000009:adverse effects
D007328:Insulin; D013453:Sulfonylurea Compounds